DocGo (DCGO) Expected to Announce Quarterly Earnings on Thursday

Key Points

• DocGo (DCGO) is set to release its Q2 2025 earnings report on Thursday, August 7th, with expected earnings of ($0.06) per share and revenues of $77.58 million.
• The company recently reported a EPS of ($0.09) for the previous quarter, missing expectations and generating a revenue of $96.03 million, lower than analyst estimates.
• Despite recent downgrades by analysts, DocGo holds a "Moderate Buy" rating with an average price target of $3.56; notable investors have increased their stakes in the company.

DocGo (NASDAQ:DCGO - Get Free Report) is expected to be issuing its Q2 2025 quarterly earnings results after the market closes on Thursday, August 7th. Analysts expect the company to announce earnings of ($0.06) per share and revenue of $77.58 million for the quarter. DocGo has set its FY 2025 guidance at EPS.

DocGo (NASDAQ:DCGO - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.08). The business had revenue of $96.03 million for the quarter, compared to analysts' expectations of $104.25 million. DocGo had a negative net margin of 0.12% and a positive return on equity of 2.52%. On average, analysts expect DocGo to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

DocGo Stock Down 2.2%

DCGO traded down $0.03 on Friday, hitting $1.33. The company had a trading volume of 568,763 shares, compared to its average volume of 459,240. The business's fifty day simple moving average is $1.50 and its 200 day simple moving average is $2.60. DocGo has a 12-month low of $1.23 and a 12-month high of $5.68. The company has a market cap of $135.63 million, a PE ratio of -66.50 and a beta of 0.96.

Analysts Set New Price Targets

DCGO has been the topic of several analyst reports. Needham & Company LLC cut their target price on DocGo from $4.00 to $3.00 and set a "buy" rating on the stock in a research report on Friday, May 9th. Canaccord Genuity Group restated a "hold" rating and set a $1.45 target price (down previously from $5.00) on shares of DocGo in a research report on Monday, May 12th. Finally, BTIG Research lowered shares of DocGo from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat.com, DocGo currently has an average rating of "Moderate Buy" and an average price target of $3.56.

Hedge Funds Weigh In On DocGo

Institutional investors have recently made changes to their positions in the company. AQR Capital Management LLC grew its holdings in DocGo by 219.1% during the 1st quarter. AQR Capital Management LLC now owns 476,645 shares of the company's stock worth $1,258,000 after acquiring an additional 327,269 shares in the last quarter. Acadian Asset Management LLC purchased a new stake in shares of DocGo in the 1st quarter worth approximately $338,000. Jane Street Group LLC boosted its stake in shares of DocGo by 18.8% during the first quarter. Jane Street Group LLC now owns 85,442 shares of the company's stock valued at $226,000 after purchasing an additional 13,505 shares in the last quarter. Finally, Strs Ohio purchased a new position in DocGo during the first quarter valued at approximately $76,000. Hedge funds and other institutional investors own 56.44% of the company's stock.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.